B3GNT5 and cancer: Additional experiments are necessary to evaluate the mechanisms by which B3GNT5-mediated interactions of cancer stem cells (CSCs) with immune cells, as well as to validate the potential of B3GNT5 as an immune checkpoint target in clinical trials.